Skip to content

Early Detection of Skin Cancer With Sensor Technology

Early Detection of Skin Cancer Using Millimetre-Wave Waveguide Reflectometers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02668614
Enrollment
60
Registered
2016-01-29
Start date
2016-02-29
Completion date
2018-02-28
Last updated
2018-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma, Basal Cell

Keywords

Detection

Brief summary

Skin cancer represents a large problem in today's healthcare setting. The majority of cancer diagnoses are attributed to malignant skin diseases including its major types: basal cell carcinoma, squamous cell carcinoma and melanoma. Early diagnoses is critical given early detection of malignant lesions largely increases chances of successful treatment. The current gold standard of diagnosis is histopathological examination of biopsied skin. Biopsies are not only invasive and expensive, they have variable positive predictive value, meaning they may often be preformed unnecessarily. As such, the investigators have developed a skin scanner, which is less bulky and expensive than existing similar technologies, as a tool to evaluate skin lesions prior to determining the need for a biopsy. Their objective is to obtain information in order to validate this skin scanner in the context of its ability to accurately identify basal cell carcinoma skin lesions.

Interventions

DEVICEWR-22 model microwave sensor

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient requiring skin biopsy for suspected basal cell carcinoma skin lesion * 18 years of age or older

Exclusion criteria

-Poor english fluency, Pregnancy

Design outcomes

Primary

MeasureTime frame
Positive predictive valueImmediately pre-biopsy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026